Comorbidities and comorbidity burden in patients with neurocognitive disorders: findings from the MEMORA Cohort Study.

ABSTRACT:

Aim

This study aimed to compare comorbidities' prevalence and the comorbidity burden as measured by comorbidity indices according to the stages and the etiological diagnoses of neurocognitive disorders (NCD). This study aimed also to examine how comorbidities and comorbidity indices were associated with both stages and etiologies of NCD.

Methods

This is a cross-sectional study including participants from the MEMORA real-life cohort, aged ≥ 60 years. Patients had to be in either MCI or dementia stage, with the following etiological diagnoses of NCD: AD, VD (vascular dementia), mixed dementia (MD), dementia with Lewy bodies, frontotemporal dementia and Parkinson's disease. Three comorbidity indices were used to measure comorbidity burden: the Charlson comorbidity index, the mu

SUBMITTER: Temedda MN 

PROVIDER: S-EPMC12743666 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature